Cargando…
Risk of Serious Bleeding with Antiplatelet Therapy for Secondary Prevention Post Ischemic Stroke in Middle East Population
Introduction Stroke is a devastating disease, causing significant mortality and long-term disability worldwide. Since the bulk of ischemic strokes is attributed to atherothrombosis, secondary prevention with antiplatelet agents is essential to decrease the recurrence of stroke. Aspirin, as well as c...
Autores principales: | Awada, Zeinab, Abboud, Rim, Nasr, Samer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697456/ https://www.ncbi.nlm.nih.gov/pubmed/31431847 http://dx.doi.org/10.7759/cureus.4942 |
Ejemplares similares
-
Antiplatelet effects of prostacyclin analogues: Which one to choose in case of thrombosis or bleeding?
por: Rogula, Sylwester P., et al.
Publicado: (2020) -
Formation of a Rectus Sheath Hematoma Secondary to COPD Exacerbation While Taking Dual Antiplatelet Therapy
por: Salem, Nicholas, et al.
Publicado: (2021) -
Reversible Cerebral Vasoconstriction Syndrome and Ischemic Stroke Secondary to Peripartum Cardiomyopathy - Report a Rare Case
por: Hang, Stephanie, et al.
Publicado: (2022) -
Dual antiplatelet therapy for secondary prevention of coronary artery disease
por: Degrauwe, Sophie, et al.
Publicado: (2017) -
Persistent Atrium Standstill Post Atrial Fibrillation Ablation Therapy
por: Khatoun, Maya A, et al.
Publicado: (2022)